Clinical Trial Update: Ease of Use and Microbial Contamination of Tobramycin Inhalation Powder (TIP) Versus Nebulised Tobramycin Inhalation Solution (TIS) and Nebulised Colistimethate (COLI) [Phase 4]

View source ↗

Summary

Phase 4 trial comparing ease of use and microbial contamination of Tobramycin Inhalation Powder (TIP) versus Nebulised Tobramycin Inhalation Solution (TIS) and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Colistimethate Inhalation Solution (COLI) (colistimethate sodium for inhalation)
• Tobramycin Inhalation Powder (TIP) (tobramycin inhalation powder)
• Tobramycin Inhalation Solution (TIS) (tobramycin inhalation solution)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Cystic Fibrosis | Phase 4 | Status: COMPLETED | Results posted: 2016-05-24